首页> 美国卫生研究院文献>other >ARTERIAL STIFFNESS A CHOICE MAKER OF THE CARDIOVASCULAR TREATMENT AT ELDERLY WITH DIABETES
【2h】

ARTERIAL STIFFNESS A CHOICE MAKER OF THE CARDIOVASCULAR TREATMENT AT ELDERLY WITH DIABETES

机译:老年糖尿病患者的动脉硬化治疗方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Introduction: Previous research has indicated that treatment with more than one antihypertensive medication class is related to elevated levels of PWV. The aim of the study was to follow the link of antihypertensive treatment and arterial stiffness at elderly with diabetes. >Methods: 143 participans were included; 81.2% female and 18.8% males; mean age was 72.28 ± 10.098 years. Parameters of arterial stiffness aPWV were measured using an oscillometric device (Arteriograph) in addition to a medical history, physical examination, and laboratory tests. Depending on the diagnosis of diabetes we have 2 groups. >Results: Age is positively correlated with Aortic PWV (r=0.65, p<0.001) and also brachial augmentation index (p=0.02) but not with diabetes. We observe a high rate of 28% converting enzyme inhibitor used in people with diabetes. The proportion of diuretic class exceeds 16% in diabetic patients compared with 10% in those without diabetes (p=0.020). Diabetic patients appear to be more educated on the importance of treatment, 61% of them constantly taking him to those without diabetes. Those with uncontrolled blood pressure group presents a mean aortic pulse wave velocity statistically significantly higher (Student t-test, p=0.043). We see a lower PWV on those who have diuretic treatment (17%). >Conclusions: The evaluation of arterial stiffness represents a valuable tool for elderly with diabetes. It should be noted that the effects of pharmacologic agents on stiffness are slight or modest, but not substantial and new therapeutic approaches to decrease arterial stiffness are needed.
机译:>简介:先前的研究表明,使用一种以上的降压药物治疗与PWV水平升高有关。该研究的目的是追踪糖尿病患者的抗高血压治疗与动脉僵硬度之间的联系。 >方法:包括143个参赛者;女性为81.2%,男性为18.8%;平均年龄为72.28±10.098岁。除了病史,体格检查和实验室检查外,还使用示波法设备(Arteriograph)测量动脉刚度aPWV的参数。根据糖尿病的诊断,我们分为2组。 >结果:年龄与主动脉PWV正相关(r = 0.65,p <0.001)和肱动脉增高指数(p = 0.02),但与糖尿病无关。我们观察到糖尿病患者使用转化酶抑制剂的比例高达28%。糖尿病患者中利尿剂的比例超过16%,而没有糖尿病的患者则为10%(p = 0.020)。糖尿病患者似乎对治疗的重要性有了更多的了解,其中61%的患者不断将他带到没有糖尿病的患者。那些血压不受控制的人群的平均主动脉脉搏波速度在统计学上显着更高(Student t-test,p = 0.043)。我们发现利尿剂治疗者的PWV较低(17%)。 >结论:评估动脉僵硬度是糖尿病老年患者的宝贵工具。应该注意的是,药理剂对僵硬的影响是轻微或中等的,但不是实质性的,需要新的治疗方法来降低动脉僵硬。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号